NCT04628767 2026-03-18
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
National Cancer Institute (NCI)
Phase 2/3 Recruiting
Clinical Trials
109 trialsNCT05987241 2026-03-18
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
National Cancer Institute (NCI)
Phase 2/3 Recruiting
NCT06780670 2026-03-16
PSMAcTION
Novartis
Phase 2/3 Recruiting
NCT07106762 2026-03-10
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Bristol-Myers Squibb
Phase 2/3 Recruiting
NCT05597878 2026-03-06
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
Wake Forest University Health Sciences
Phase 2/3 Suspended
NCT07129993 2026-03-05
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Daiichi Sankyo
Phase 2/3 Recruiting
NCT07426055 2026-02-23
PRO-BOOST-LC
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Not yet recruiting
NCT07426094 2026-02-23
PRO-BOOST-N
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Not yet recruiting
NCT06225596 2026-02-17
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
BicycleTx Limited
Phase 2/3 Recruiting
NCT03070886 2026-01-14
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
NRG Oncology
Phase 2/3 Completed
NCT03258320 2026-01-12
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Recruiting
NCT00117286 2025-12-18
Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer
Ferring Pharmaceuticals
Phase 2/3 Completed
NCT03701581 2025-12-17
4-aminopyridine Treatment for Nerve Injury
University of Arizona
Phase 2/3 Recruiting
NCT07084909 2025-12-10
HARRIER
Lantheus Medical Imaging
Phase 2/3 Withdrawn
NCT06861192 2025-11-18
Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer
Zhongda Hospital
Phase 2/3 Recruiting
NCT03022825 2025-10-16
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
ImmunityBio, Inc.
Phase 2/3 Active not recruiting
NCT03772834 2025-10-10
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer
M.D. Anderson Cancer Center
Phase 2/3 Active not recruiting
NCT07209878 2025-10-07
68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
First Affiliated Hospital of Fujian Medical University
Phase 2/3 Recruiting
NCT07198451 2025-09-30
GEM-IR-NMIBC
Shanghai University of Traditional Chinese Medicine
Phase 2/3 Not yet recruiting
NCT07156786 2025-09-19
N-Acetylcysteine Roles in Preserving Renal Function Measured by Urinary KIM-1 (Kidney Injury Molecule-1) and Serum Creatinine on Cancer Patients With Cisplatin Based Chemotherapy: A Randomized Placebo-Controlled Trial
Fakultas Kedokteran Universitas Indonesia
Phase 2/3 Not yet recruiting
NCT06124976 2025-09-15
Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
University of British Columbia
Phase 2/3 Recruiting
NCT03348670 2025-08-17
Drugs-SNPs
Medicine Invention Design, Inc
Phase 2/3 Active not recruiting
NCT05137561 2025-08-07
PROBIOP
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 2/3 Completed
NCT06537154 2025-07-30
NEO-BLAST
University of British Columbia
Phase 2/3 Recruiting
NCT05920343 2025-07-10
PREVENT-GU
Ottawa Hospital Research Institute
Phase 2/3 Recruiting
NCT06879145 2025-06-18
Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2/3 Recruiting
NCT06972511 2025-05-15
Maximal Tumor Eradication for Oligometastatic Prostate Cancer
RenJi Hospital
Phase 2/3 Recruiting
NCT03706365 2025-04-20
CYCLONE 2
Eli Lilly and Company
Phase 2/3 Active not recruiting
NCT03822845 2025-04-17
Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer
University of Iowa
Phase 2/3 Completed
NCT06493552 2025-04-03
Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors
Vasgene Therapeutics, Inc
Phase 2/3 Recruiting
NCT03525288 2025-03-13
PSMA-PETgRT
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 2/3 Active not recruiting
NCT06861166 2025-03-06
Clinical Study of Geranium Wilfordii Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer
Zhongda Hospital
Phase 2/3 Not yet recruiting
NCT02984124 2025-02-18
CHART
University of Vermont
Phase 2/3 Active not recruiting
NCT05381103 2025-01-31
PSMA-PET to Guide Prostatectomy
Five Eleven Pharma, Inc.
Phase 2/3 Recruiting
NCT02685397 2024-12-04
PCS IX
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2/3 Active not recruiting
NCT06601205 2024-09-19
2F
Ente Ospedaliero Ospedali Galliera
Phase 2/3 Completed
NCT03389451 2024-07-12
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer
University of Iowa
Phase 2/3 Completed
NCT05627752 2024-02-28
Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage
Zhongnan Hospital
Phase 2/3 Unknown
NCT06282588 2024-02-28
THUNDER
Cancer Research Antwerp
Phase 2/3 Recruiting
NCT03388346 2024-02-15
68Ga PSMA in Preprostatectomy Patients
University of Iowa
Phase 2/3 Completed
NCT04242017 2023-12-13
LOBSTER
Universitaire Ziekenhuizen KU Leuven
Phase 2/3 Recruiting
NCT03459820 2023-11-27
Prostate Cancer Patient Management With 18F-DCFPyL PET/CT
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2/3 Enrolling by invitation
NCT00584532 2023-11-24
GCP
University of California, Davis
Phase 2/3 Completed
NCT04654338 2023-06-27
EARTH
Sunnybrook Health Sciences Centre
Phase 2/3 Recruiting
NCT05841992 2023-05-03
Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients
Peking Union Medical College Hospital
Phase 2/3 Unknown
NCT01907009 2023-04-19
MEL-CAP
Barts & The London NHS Trust
Phase 2/3 Terminated
NCT00268476 2023-04-18
STAMPEDE
Medical Research Council
Phase 2/3 Active not recruiting
NCT02624518 2023-04-10
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
Stanford University
Phase 2/3 Completed
NCT03103152 2023-03-29
PROVENT
Queen Mary University of London
Phase 2/3 Completed
NCT04627896 2023-02-02
Targeted Microwave Focal Therapy
A.O.U. Città della Salute e della Scienza
Phase 2/3 Completed